KLRS
Kalaris Therapeutics, Inc.
Set alert
2.03 USD -0.10 -4.69%
1.97 Day range 2.08
1.80 52-week range 10.98
- YTD
- -75.95%
- 1 year
- -57.17%
- Open
- 1.98
- Prev close
- 2.13
- Mkt cap
- 48.32M
- Vol
- 60.20K
- Avg vol
- 68.90K
- EPS
- -2.02
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.97
- High
- 2.08
Financials — quick view
KLRS Revenue — quarterly 0
KLRS Net income — quarterly -11.52M
KLRS EPS — quarterly -0.48
News
- Alpha Buying: 3 Beaten-Down Biotech Stocks Backed by a Specialist Investor
- 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- Kalaris Therapeutics Inc. (NASDAQ:KLRS) Stock Has Average Price Target of $18.75
- Kalaris to Present at Morgan Stanley 24th Annual Global Healthcare Conference
- Kalaris Therapeutics Q2 EPS $(0.48) Beats $(0.49) Estimate
- Kalaris Reports Second Quarter 2026 Financial Results and Provides Business Updates
- Kalaris Therapeutics (NASDAQ:KLRS) Shares Up 15.4% – Here’s What Happened
- KLRS: Abbott Cooper PLLC Announces Investigation on Behalf of Kalaris Therapeutics, Inc. (Formerly Allovir, Inc.) Stockholders
- Kalaris Therapeutics Appoints Liisa Bayko CFO
Your note
Sign in to keep a note on KLRS — it syncs with the Stock Master app.